Critical parameters for genome editing using zinc finger nucleases

Todd D. Camenisch, Murray H. Brilliant, David Segal

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The possibility to make precise modifications to the genome at high frequency holds tremendous potential for biotechnology, conventional drug development and gene therapy. Homologous recombination is a powerful method for introducing such modifications in organisms such as mice. However, in mammals and plants, the frequency of gene modification by homologous recombination is quite low, precluding the therapeutic use of this methodology. In the past few years, tremendous progress has been made in overcoming one of primary barriers to efficient recombination, namely the introduction of a targeted double-strand break near the intended recombination site. This review will discuss the advances in engineering custom zinc-finger nucleases and their application in stimulating homologous recombination in higher eukaryotic cells at efficiencies approaching 1 in 2 cells.

Original languageEnglish (US)
Pages (from-to)669-676
Number of pages8
JournalMini-Reviews in Medicinal Chemistry
Volume8
Issue number7
DOIs
StatePublished - 2008

Fingerprint

Homologous Recombination
Zinc Fingers
Zinc
Genes
Gene therapy
Genetic Recombination
Mammals
Biotechnology
Plant Genes
Eukaryotic Cells
Therapeutic Uses
Genetic Therapy
Pharmaceutical Preparations
Genome
Drug Therapy
Gene Editing

Keywords

  • Animal models
  • Gene therapy
  • Homologous recombination
  • Protein-DNA interactions
  • Targeted mutagenesis

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Chemistry(all)
  • Pharmacology

Cite this

Critical parameters for genome editing using zinc finger nucleases. / Camenisch, Todd D.; Brilliant, Murray H.; Segal, David.

In: Mini-Reviews in Medicinal Chemistry, Vol. 8, No. 7, 2008, p. 669-676.

Research output: Contribution to journalArticle

Camenisch, Todd D. ; Brilliant, Murray H. ; Segal, David. / Critical parameters for genome editing using zinc finger nucleases. In: Mini-Reviews in Medicinal Chemistry. 2008 ; Vol. 8, No. 7. pp. 669-676.
@article{0d661ef8b4d644bea21ac43de3f30097,
title = "Critical parameters for genome editing using zinc finger nucleases",
abstract = "The possibility to make precise modifications to the genome at high frequency holds tremendous potential for biotechnology, conventional drug development and gene therapy. Homologous recombination is a powerful method for introducing such modifications in organisms such as mice. However, in mammals and plants, the frequency of gene modification by homologous recombination is quite low, precluding the therapeutic use of this methodology. In the past few years, tremendous progress has been made in overcoming one of primary barriers to efficient recombination, namely the introduction of a targeted double-strand break near the intended recombination site. This review will discuss the advances in engineering custom zinc-finger nucleases and their application in stimulating homologous recombination in higher eukaryotic cells at efficiencies approaching 1 in 2 cells.",
keywords = "Animal models, Gene therapy, Homologous recombination, Protein-DNA interactions, Targeted mutagenesis",
author = "Camenisch, {Todd D.} and Brilliant, {Murray H.} and David Segal",
year = "2008",
doi = "10.2174/138955708784567458",
language = "English (US)",
volume = "8",
pages = "669--676",
journal = "Mini-Reviews in Medicinal Chemistry",
issn = "1389-5575",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - Critical parameters for genome editing using zinc finger nucleases

AU - Camenisch, Todd D.

AU - Brilliant, Murray H.

AU - Segal, David

PY - 2008

Y1 - 2008

N2 - The possibility to make precise modifications to the genome at high frequency holds tremendous potential for biotechnology, conventional drug development and gene therapy. Homologous recombination is a powerful method for introducing such modifications in organisms such as mice. However, in mammals and plants, the frequency of gene modification by homologous recombination is quite low, precluding the therapeutic use of this methodology. In the past few years, tremendous progress has been made in overcoming one of primary barriers to efficient recombination, namely the introduction of a targeted double-strand break near the intended recombination site. This review will discuss the advances in engineering custom zinc-finger nucleases and their application in stimulating homologous recombination in higher eukaryotic cells at efficiencies approaching 1 in 2 cells.

AB - The possibility to make precise modifications to the genome at high frequency holds tremendous potential for biotechnology, conventional drug development and gene therapy. Homologous recombination is a powerful method for introducing such modifications in organisms such as mice. However, in mammals and plants, the frequency of gene modification by homologous recombination is quite low, precluding the therapeutic use of this methodology. In the past few years, tremendous progress has been made in overcoming one of primary barriers to efficient recombination, namely the introduction of a targeted double-strand break near the intended recombination site. This review will discuss the advances in engineering custom zinc-finger nucleases and their application in stimulating homologous recombination in higher eukaryotic cells at efficiencies approaching 1 in 2 cells.

KW - Animal models

KW - Gene therapy

KW - Homologous recombination

KW - Protein-DNA interactions

KW - Targeted mutagenesis

UR - http://www.scopus.com/inward/record.url?scp=46749149696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749149696&partnerID=8YFLogxK

U2 - 10.2174/138955708784567458

DO - 10.2174/138955708784567458

M3 - Article

C2 - 18537722

AN - SCOPUS:46749149696

VL - 8

SP - 669

EP - 676

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

IS - 7

ER -